Black currant is a purple berry yielding oral extract and seed oil supplements for exercise, blood flow, and immunity. Sufficient or multi-day extracts strongly improve fat burning, artery flexibility, and mealtime blood sugar and moderately support bones and eyes; seed oil moderately supports joints and immunity. Gut, blood pressure, cholesterol, and memory evidence is low and conflicted, longevity is confined to yeast and mice, and capsules avoid tooth erosion. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting Glucose & HOMA-IR | Glucose: 70–99 mg/dL (standard reference range); HOMA-IR: No established target; tracked via reduction from individual baseline | Efficacy marker: 8-day extract (600 mg/day) improves insulin sensitivity by 22% and lowers post-meal glucose excursions. |
| Fasting Triglycerides | <150 mg/dL (standard reference range) | Efficacy marker: 6-month extract (784 mg/day) dose-dependently lowers fasting plasma triglycerides. |
| hs-CRP | <3.0 mg/L (standard reference range) | Efficacy marker: anthocyanin supplementation reduces systemic hs-CRP in overweight and metabolic syndrome adults. |
| Whole-Body BMD (DXA) & Serum P1NP | Whole-body BMD: No established target; tracked for stability or gain vs. baseline; P1NP: 19–83 μg/L (standard reference range) | Efficacy marker: 784 mg/day extract preserves 6-month whole-body BMD and elevates P1NP in menopausal women. |
| Intraocular Pressure & Humphrey Visual Field MD | Intraocular pressure: 10–21 mmHg (standard reference range); Visual field MD: No established target; tracked for stability versus baseline | Efficacy marker: 50 mg/day anthocyanins slow visual field MD deterioration and lower intraocular pressure. |
| INR / Prothrombin Time (anticoagulated users) | 0.8–1.1 (standard reference range) | Safety check: anthocyanins and seed oil inhibit platelet activation and may potentiate anticoagulant bleeding risk. |
Cadence: Baseline; 1–2 weeks for acute glycemic/exercise responses and INR (after starting or stopping in warfarin users); 8 weeks and every 3–6 months for fasting metabolic, triglyceride, and hs-CRP panels; every 6–12 months for DXA bone density, serum P1NP (6 months), and ophthalmic visual field/tonometry (every 6 months).